MagnaChip Semiconductor Corporation (NYSE:MX) last session’s volume of 0.22 million shares was lower than its average volume of 0.53 million shares. The stock, after opening at $8.35, hit $8.4 through the close by scoring 0%.MagnaChip Semiconductor Corporation (MX) Analyst Opinion
MagnaChip Semiconductor Corporation has a consensus outperform rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 8.64% of shares outstanding. The stock spiked 2.44% last month and is up 35.48 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover MX having a buy-equivalent rating. Analysts have placed a $10.5 price target on MagnaChip Semiconductor Corporation, suggesting a 25% gain from recent close. It’s currently trading about -13.4% below its 52-week high.MagnaChip Semiconductor Corporation Earnings Surprise
MagnaChip Semiconductor Corporation (MX) failed to surprise the stock market in its last reported earnings when it earned $0.04 a piece versus the consensus-estimated $0.07. Its revenue totaled $180 million down -6.4% from the previous quarter. The good news is, sales may return to growth this quarter. As per the consensus estimate, the company’s year-on-year revenue growth is expected to be at 8.04% during the period. Last year, it had about $148.1 million of revenue.
This stock (MX) is ahead of its 52-week low with 78.34%. Its last month’s stock price volatility remained 3.36% which for the week stands at 3.97%. The share price has moved backward from its 20 days moving average, trading at a distance of -6.3% and stays 2.31% away from its 50 days moving average. Over the last five days, shares have faced -7.18% losses and now is up 14.04% since hitting its 200-day moving average of $7.45. MagnaChip Semiconductor Corporation (MX) has made its way to a 12-month gain of 58.79%.
Turning to Clearside Biomedical (NASDAQ:CLSD), its shares were trading at $7.49 a retreat of $-0.22, on the trading floor. The stock, after opening at $7.71, touched a high of $7.86 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.6. Clearside Biomedical has 2 buy ratings, 0 holds and 0 sells even after the stock tumbled -70.14% from its high of $25.08 to a $189.42 million market value through last close.Clearside Biomedical (CLSD) Consensus Price Target
The company’s consensus rating on Reuter’s scale remained unchanged from 1.6 to 1.6 during a month. Analysts set a 12-month price target of $21.25 a share. The target implies a 183.71% spike from where the shares are currently trading. Also, the current price highlights a discount of 260.48% to analysts’ high consensus price target.Clearside Biomedical (NASDAQ:CLSD) Intraday Trading
The counter witnessed a trading volume of 0.16 million shares versus an average volume of 0.19 million shares during last trading session. Its last month’s stock price volatility remained 5.57% which for the week approaches 6.05%. The lowest price the stock reached in the last trading day was $7.25 and compares with the $5.44 52-week low. The stock recovered 37.68% since its low point and has performed -16.22% year-to-date.